These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2190380)

  • 41. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 45. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
    Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
    Griffey MA; Hock KG; Kilgore DC; Wei TQ; Duh SH; Christenson R; Scott MG
    Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oral cyclosporine pharmacokinetics in renal transplantation patients].
    Zhuo HT; Chen G
    Yao Xue Xue Bao; 1990; 25(1):1-5. PubMed ID: 2363351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 49. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

  • 51. [Organ xenotransplantation (Review of foreign literature)].
    Zhavoronkov NA
    Khirurgiia (Mosk); 1993 Jun; (6):89-94. PubMed ID: 8246394
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of an LC-MS method for plasma quantification of the new immunosuppressant FK778 through comparison with HPLC-UV.
    Molinaro M; Carazzone C; Barbano D; Abbiati F; Alessiani M; Regazzi M
    Transplant Proc; 2005; 37(6):2722-7. PubMed ID: 16182794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combined organ effect: protection against rejection?
    Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
    Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seeking the perfect match. HLA and transplantation.
    Tait BD
    Med J Aust; 1993 Nov; 159(10):696-700. PubMed ID: 8232014
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclosporine and the liver: how one affects the other.
    de Groen PC
    Transplant Proc; 1990 Jun; 22(3):1197-202. PubMed ID: 2190381
    [No Abstract]   [Full Text] [Related]  

  • 57. Biologic activity of cyclosporine metabolites.
    Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
    Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical relevance of cytotoxic T-cell precursor (p-CTL) frequencies in allograft recipients.
    Steinmann J; Leimenstoll G; Engemann R; Weyand M; Westphal E; Müller-Ruchholtz W
    Transplant Proc; 1990 Aug; 22(4):1873. PubMed ID: 2389466
    [No Abstract]   [Full Text] [Related]  

  • 59. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of a fluorescence polarization immunoassay and a radioimmunoassay for the quantitation of cyclosporine A in organ transplantation.
    Wallemacq PE; Mücke K; De Somer M; Squifflet JP; Otte JB; Goenen M; Ferrant A; Jacqmin PA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):888-91. PubMed ID: 2650290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.